(NASDAQ: CGEN) Compugen's forecast annual revenue growth rate of 23.56% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 55.82%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.32%.
Compugen's revenue in 2025 is $27,589,000.On average, 4 Wall Street analysts forecast CGEN's revenue for 2025 to be $1,323,150,992, with the lowest CGEN revenue forecast at $205,944,866, and the highest CGEN revenue forecast at $2,686,237,380. On average, 3 Wall Street analysts forecast CGEN's revenue for 2026 to be $3,630,270,737, with the lowest CGEN revenue forecast at $1,969,907,412, and the highest CGEN revenue forecast at $4,477,062,300.
In 2027, CGEN is forecast to generate $4,391,371,328 in revenue, with the lowest revenue forecast at $2,238,531,150 and the highest revenue forecast at $6,010,903,844.